Aethlon Historical Cash Flow
| AEMD Stock | USD 0.61 0.02 3.39% |
Analysis of Aethlon Medical cash flow over time is an excellent tool to project Aethlon Medical future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 15.4 M or Other Non Cash Items of 22.3 K as it is a great indicator of Aethlon Medical ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Aethlon Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Aethlon Medical is a good buy for the upcoming year.
Aethlon |
About Aethlon Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Aethlon balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Aethlon's non-liquid assets can be easily converted into cash.
Aethlon Medical Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Aethlon Medical to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Aethlon Medical operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Aethlon Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Aethlon Medical current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.At present, Aethlon Medical's Begin Period Cash Flow is projected to increase significantly based on the last few years of reporting. The current year's Other Non Cash Items is expected to grow to about 22.3 K, whereas Free Cash Flow is projected to grow to (9.9 M).
Aethlon Medical cash flow statement Correlations
Click cells to compare fundamentals
Aethlon Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Aethlon Medical cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 5.8M | 303.5K | 7.3M | (2.5M) | (9.1M) | (8.6M) | |
| Free Cash Flow | (5.3M) | (6.8M) | (10.1M) | (11.4M) | (10.4M) | (9.9M) | |
| Change In Working Capital | (115.0K) | 309.7K | (251.1K) | 65.3K | 478.7K | 502.6K | |
| Begin Period Cash Flow | 3.8M | 9.6M | 9.9M | 17.2M | 14.6M | 15.4M | |
| Other Non Cash Items | 31.3K | (2.5K) | 30.5K | (46.6M) | 21.3K | 22.3K | |
| Total Cash From Operating Activities | (5.2M) | (6.8M) | (9.8M) | (10.5M) | (10.1M) | (9.6M) | |
| Net Income | (6.4M) | (7.9M) | (10.4M) | (12.0M) | (12.2M) | (11.6M) | |
| End Period Cash Flow | 9.6M | 9.9M | 17.2M | 14.6M | 5.5M | 3.0M | |
| Depreciation | 26.4K | 39.9K | 123.7K | 240.9K | 359.1K | 377.0K | |
| Total Cash From Financing Activities | 11.1M | 7.1M | 17.4M | 8.9M | 1.3M | 1.2M | |
| Change To Liabilities | 111.3K | 356.7K | 327.2K | (519.3K) | (467.3K) | (444.0K) | |
| Change To Account Receivables | 74.8K | (206.7K) | 57.6K | 21.1K | 128.0K | 0.0 | |
| Stock Based Compensation | 844.0K | 779.4K | 750.6K | 1.1M | 1.2M | 1.1M | |
| Sale Purchase Of Stock | (40.9K) | (132.5K) | (88.1K) | (12.5K) | (11.2K) | (10.7K) | |
| Change To Inventory | (74.8K) | 8.5K | (104.7K) | 456.6K | 411.0K | 431.5K | |
| Change Receivables | (74.8K) | 74.8K | (206.7K) | 57.6K | 66.3K | 69.6K | |
| Cash And Cash Equivalents Changes | 5.4M | (3.1M) | 5.8M | 303.5K | 349.0K | 331.6K | |
| Cash Flows Other Operating | (17.0K) | (22.6K) | (19.6K) | (111.5K) | (100.3K) | (95.3K) | |
| Change To Netincome | 1.2M | 772.1K | 776.4K | 1.2M | 1.1M | 1.6M | |
| Investments | (151.7K) | (59.9K) | (349.2K) | (943.1K) | (250.9K) | (263.4K) | |
| Change To Operating Activities | 8.5K | (104.7K) | (599.5K) | 456.6K | 525.1K | 551.4K | |
| Issuance Of Capital Stock | 12.2M | 7.3M | 17.5M | 8.9M | 1.3M | 1.3M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Aethlon Medical is a strong investment it is important to analyze Aethlon Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aethlon Medical's future performance. For an informed investment choice regarding Aethlon Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.79) | Revenue Per Share 0.236 | Quarterly Revenue Growth 42.782 | Return On Assets (0.50) | Return On Equity (1.05) |
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.